Corrigendum to “Emerging strategy for the treatment of urothelial carcinoma: Advances in antibody-drug conjugates combination therapy” Biomed. Pharmacother. 171 (2024) 116152
Xiangyun You,
Chunming Zhu,
Puguang Yu,
Xia Wang,
Yibing Wang,
Jiahe Wang,
Junfeng Yu,
Kefeng Wang
Affiliations
Xiangyun You
Department of Urology, Shengjing Hospital of China Medical University, Shenyang 110004, China; Department of Urology, The First College of Clinical Medical Science, China Three Gorges University, Yichang 443000, China
Chunming Zhu
Department of Family Medicine, Shengjing Hospital of China Medical University, Shenyang 110004, China
Puguang Yu
Department of Urology, Shengjing Hospital of China Medical University, Shenyang 110004, China
Xia Wang
Department of Urology, Shengjing Hospital of China Medical University, Shenyang 110004, China
Yibing Wang
Department of Urology, Shengjing Hospital of China Medical University, Shenyang 110004, China; Correspondence to: #36 Sanhao Street, Heping District, Shenyang, Liaoning, China.
Jiahe Wang
Department of Family Medicine, Shengjing Hospital of China Medical University, Shenyang 110004, China; Correspondence to: #36 Sanhao Street, Heping District, Shenyang, Liaoning, China.
Junfeng Yu
Department of Urology, The First College of Clinical Medical Science, China Three Gorges University, Yichang 443000, China; Correspondence to: #2 Jiefang Street, Xiling District, Yichang, Hubei, China.
Kefeng Wang
Department of Urology, Shengjing Hospital of China Medical University, Shenyang 110004, China; Correspondence to: #36 Sanhao Street, Heping District, Shenyang, Liaoning, China.
